Jeffrey Zaltzman




Dr. Jeffrey Zaltzman graduated with both his undergraduate degree and MD from McGill University. He completed a residency in Internal Medicine at the University of Manitoba, in addition to Nephrology and Transplant training at the University of Toronto, where he also received a MSc in Clinical Epidemiology.

Dr. Zaltzman joined the Division of Nephrology at St. Michael’s Hospital in 1993, where played an active role in the resurgence of the kidney transplant program. In 2000, he was appointed as the Director of the Renal Transplant Program. Dr. Zaltzman has also served as the Director of the Internal Medicine Residency Program at St. Michael’s Hospital and has also been involved in research ethics, where he served as the Chair of the Research Ethics Board (REB) from 2000-2002.

He continues to serve as Educational Director of Nephrology at St. Michael’s Hospital. He is the Medical Director of the Diabetes Comprehensive Care Program, in addition to the Chief Medical Officer, Transplant of Trillium Gift of Life. He currently Chairs the Canadian Society of Transplantation Kidney Working group. He was actively involved with the Kidney Foundation of Canada in both the provincial and national levels. His research interests are in the areas of chronic allograft nephropathy, cardiovascular issues, and renal function in transplantation and transplant ethics. He has over 80 peer-reviewed publications.

Please note: Dr. Zaltzman is not taking any summer students.

Recent Publications

  1. Garg, AX, Yohanna, S, Naylor, KL, McKenzie, SQ, Mucsi, I, Dixon, SN et al.. Effect of a Novel Multicomponent Intervention to Improve Patient Access to Kidney Transplant and Living Kidney Donation: The EnAKT LKD Cluster Randomized Clinical Trial. JAMA Intern Med. 2023;183 (12):1366-1375. doi: 10.1001/jamainternmed.2023.5802. PubMed PMID:37922156 PubMed Central PMC10696487.
  2. Dixon, SN, Naylor, KL, Yohanna, S, McKenzie, S, Belenko, D, Blake, PG et al.. Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD): Statistical Analysis Plan of a Registry-Based, Cluster-Randomized Clinical Trial. Can J Kidney Health Dis. 2022;9 :20543581221131201. doi: 10.1177/20543581221131201. PubMed PMID:36438439 PubMed Central PMC9693773.
  3. Dharia, AA, Huang, M, Nash, MM, Dacouris, N, Zaltzman, JS, Prasad, GVR et al.. Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys. BMC Nephrol. 2022;23 (1):97. doi: 10.1186/s12882-022-02718-6. PubMed PMID:35247959 PubMed Central PMC8898413.
  4. Naccarato, M, Kwee, F, Zaltzman, J, Fong, IW. Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?. AIDS. 2021;35 (12):2065-2068. doi: 10.1097/QAD.0000000000003002. PubMed PMID:34471078 .
  5. Herblum, J, Dacouris, N, Huang, M, Zaltzman, J, Prasad, GVR, Nash, M et al.. Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication Adherence. Can J Kidney Health Dis. 2021;8 :20543581211021742. doi: 10.1177/20543581211021742. PubMed PMID:34188946 PubMed Central PMC8209833.
  6. Yohanna, S, Naylor, KL, Mucsi, I, McKenzie, S, Belenko, D, Blake, PG et al.. A Quality Improvement Intervention to Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD) in Patients With Chronic Kidney Disease: Clinical Research Protocol of a Cluster-Randomized Clinical Trial. Can J Kidney Health Dis. 2021;8 :2054358121997266. doi: 10.1177/2054358121997266. PubMed PMID:33948191 PubMed Central PMC8054216.
  7. Pavenski, K, Bucholz, M, Cheatley, PL, Krok, E, Anderson, M, Prasad, GR et al.. The First North American Experience Using Glycosorb Immunoadsorption Columns for Blood Group-Incompatible Kidney Transplantation. Can J Kidney Health Dis. 2020;7 :2054358120962586. doi: 10.1177/2054358120962586. PubMed PMID:33101699 PubMed Central PMC7549322.
  8. Yau, K, Muller, MP, Lin, M, Siddiqui, N, Neskovic, S, Shokar, G et al.. COVID-19 Outbreak in an Urban Hemodialysis Unit. Am J Kidney Dis. 2020;76 (5):690-695.e1. doi: 10.1053/j.ajkd.2020.07.001. PubMed PMID:32681983 PubMed Central PMC7362862.
  9. Ball, IM, Hornby, L, Rochwerg, B, Weiss, MJ, Gillrie, C, Chassé, M et al.. Management of the neurologically deceased organ donor: A Canadian clinical practice guideline. CMAJ. 2020;192 (14):E361-E369. doi: 10.1503/cmaj.190631. PubMed PMID:32392524 PubMed Central PMC7145376.
  10. Vadas, P, Ho, A, Zaltzman, J. In reply: Assessing the need for a chlorhexidine-containing central venous catheter: balancing the risk of anaphylaxis with infection. Can J Anaesth. 2020;67 (7):915. doi: 10.1007/s12630-020-01599-3. PubMed PMID:32103420 .
Search PubMed

Affiliations & Other Activities

  • Director, Diabetes Comprehensive Care Program, St. Michael’s Hospital
  • Director, Renal Transplant Program, Division of Nephrology, St.Michael’s Hospital
  • Professor of Medicine, University of Toronto Chief Medical Officer, Trillium Gift of Life